US Edition
L'Oreal to acquire majority stake in British Medik8
- On Monday, June 9, 2025, L'Oréal announced it had secured controlling interest in Medik8, a UK-based premium skincare company.
- The deal follows L'Oréal's drive to revive growth through acquisitions amid a slowdown in its dermatological beauty division.
- Established in 2009 by UK-based scientist Elliot Isaacs, Medik8 is a rapidly growing brand in English-speaking markets, known for its vitamin A-centered anti-aging skincare products.
- The brand reported £15.6 million pre-tax profit on £45.3 million revenues for year ending September 2023 and is praised for integrating science and innovation.
- The acquisition boosts L'Oréal's dermatological skincare presence and supports Medik8's global expansion with access to L'Oréal's research and market expertise.
Insights by Ground AI
Does this summary seem wrong?
23 Articles
23 Articles
All
Left
2
Center
2
Right
4
With the acquisition of this British company, the French cosmetics group expands its portfolio of high-end care.
·Paris, France
Read Full Article
Coverage Details
Total News Sources23
Leaning Left2Leaning Right4Center2Last UpdatedBias Distribution50% Right
Bias Distribution
- 50% of the sources lean Right
50% Right
L 25%
C 25%
R 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
